Research
Studies, regulatory alerts and plain-language explainers on peptide testing, market quality and how to read a certificate of analysis.
Study2017Half of 'SARMs' sold online weren't what the label said
A 2017 JAMA study found only about half of products sold online as SARMs actually contained a SARM, and many held a different unapproved drug instead.
Study2024Online semaglutide: low purity, wrong amounts, and endotoxin
Test purchases of online 'semaglutide' found purity around 7-14% against 99% advertised, wrong amounts, and elevated endotoxin in one sample.
Explainer2024A label is a claim, not a result
Why identity, purity, and content are three different questions — and why a label answers none of them.
Study2017Half of 'SARMs' sold online weren't what the label said
A 2017 JAMA study found only about half of products sold online as SARMs actually contained a SARM, and many held a different unapproved drug instead.
Study2024Online semaglutide: low purity, wrong amounts, and endotoxin
Test purchases of online 'semaglutide' found purity around 7-14% against 99% advertised, wrong amounts, and elevated endotoxin in one sample.
Study2024How researchers audit an online peptide market
How researchers map and audit an unregulated online peptide market, from search surveillance to lab testing.
Regulator2023FDA: BPC-157 and other peptides flagged for significant safety risks
In September 2023 the FDA placed BPC-157 on its list of bulk drug substances that may present significant safety risks for compounding.
Regulator2024Why peptide impurities matter: FDA on aggregates and immunogenicity
An FDA advisory committee presentation explained how peptide impurities, including aggregates, can raise immunogenicity risk.
Regulator2026FDA warns about fraudulent and unapproved GLP-1 products
The FDA has warned about fraudulent and unapproved compounded GLP-1 products, including false labels and dosing-error adverse events.
Regulator2024WHO: at least 1 in 10 medicines in low- and middle-income countries is substandard or falsified
The WHO estimates at least 1 in 10 medicines in low- and middle-income countries is substandard or falsified.
Study2012The 2012 fungal meningitis outbreak: what a sterility failure looks like
A 2012 sterility failure in compounded steroid injections sickened more than 700 people across 20 states and killed 64.
Explainer2024A label is a claim, not a result
Why identity, purity, and content are three different questions — and why a label answers none of them.
Explainer2024Endotoxin explained
What endotoxin is, why ordinary sterile filtration does not remove it, and how the LAL test measures it.
Explainer2024Sterility vs bioburden
USP <61> counts living microbes; USP <71> is a 14-day pass/fail sterility test. A count is not a sterility claim.
Explainer2024Purity is not content: HPLC, LC-MS and net peptide content
Three measurements that sound similar but answer different questions — and why a vial can be high purity and under-filled, or over-filled with low purity.
Explainer2024Heavy metals in synthesized products
Arsenic, cadmium, lead and mercury — where they come from, how they are measured, and the limits that apply.
Explainer2024Peptide impurities and why they matter
Deletion sequences, oxidation products, aggregates and synthesis byproducts — and why an impurity profile belongs on a COA.
Explainer2024How to read a COA: 12 red flags
Twelve warning signs that a certificate of analysis is not what it claims to be — and how our certificate answers each one.
Explainer2024Research use only: what the label means and where regulators stand
What 'research use only' actually means, and how the FDA's position on peptides and unapproved GLP-1s frames it.
